The twin-arginine translocation (Tat) machinery transports folded proteins across the cytoplasmic membrane of bacteria and the thylakoid membrane of chloroplasts. It has been inferred that the Tat translocation site is assembled on demand by substrate-induced association of the protein TatA. We tested this model by imaging YFP-tagged TatA expressed at native levels in living Escherichia coli cells in the presence of low levels of the TatA paralogue TatE. Under these conditions the TatA-YFP fusion supports full physiological Tat transport activity. In agreement with the TatA association model, raising the number of transport-competent substrate proteins within the cell leads to an increase in the number of large TatA complexes present. Formation of these complexes requires both a functional TatBC substrate receptor and the transmembrane proton motive force (PMF). Removing the PMF causes TatA complexes to dissociate, except in strains with impaired Tat transport activity. Based on these observations we propose that TatA assembly reaches a critical point at which oligomerization can be reversed only by substrate transport. In contrast to TatA-YFP, the oligomeric states of TatB-YFP and TatC-YFP fusions are not affected by substrate or the PMF, although TatB-YFP oligomerization does require TatC. B acteria and archaea possess two parallel pathways for the routine export of proteins across the cytoplasmic membrane. The Sec (secretion) pathway threads unstructured proteins across the membrane through an aqueous channel (1), whereas the Tat (twin-arginine translocation) pathway transports folded proteins using a currently uncharacterized mechanism (2, 3). The Tat transport system has the greater mechanistic challenge, not only because folded proteins require a wider transport pathway, but because proteins have very different sizes and shapes when folded making it difficult to seal tightly around the protein during transport. Thus elucidating the unusual mechanism of Tat transport is of great interest. Substrate movement through the Sec transporter is driven by a combination of ATP hydrolysis and the transmembrane proton motive force (PMF). In contrast, Tat transport is energized solely by the PMF (4, 5). Sec and Tat pathways are conserved in the thylakoid membranes of chloroplasts where they mediate protein transport into the thylakoid lumen (6).
The twin-arginine translocation (Tat) machinery transports folded proteins across the cytoplasmic membrane of bacteria and the thylakoid membrane of chloroplasts. It has been inferred that the Tat translocation site is assembled on demand by substrate-induced association of the protein TatA. We tested this model by imaging YFP-tagged TatA expressed at native levels in living Escherichia coli cells in the presence of low levels of the TatA paralogue TatE. Under these conditions the TatA-YFP fusion supports full physiological Tat transport activity. In agreement with the TatA association model, raising the number of transport-competent substrate proteins within the cell leads to an increase in the number of large TatA complexes present. Formation of these complexes requires both a functional TatBC substrate receptor and the transmembrane proton motive force (PMF). Removing the PMF causes TatA complexes to dissociate, except in strains with impaired Tat transport activity. Based on these observations we propose that TatA assembly reaches a critical point at which oligomerization can be reversed only by substrate transport. In contrast to TatA-YFP, the oligomeric states of TatB-YFP and TatC-YFP fusions are not affected by substrate or the PMF, although TatB-YFP oligomerization does require TatC. B acteria and archaea possess two parallel pathways for the routine export of proteins across the cytoplasmic membrane. The Sec (secretion) pathway threads unstructured proteins across the membrane through an aqueous channel (1) , whereas the Tat (twin-arginine translocation) pathway transports folded proteins using a currently uncharacterized mechanism (2, 3) . The Tat transport system has the greater mechanistic challenge, not only because folded proteins require a wider transport pathway, but because proteins have very different sizes and shapes when folded making it difficult to seal tightly around the protein during transport. Thus elucidating the unusual mechanism of Tat transport is of great interest. Substrate movement through the Sec transporter is driven by a combination of ATP hydrolysis and the transmembrane proton motive force (PMF). In contrast, Tat transport is energized solely by the PMF (4, 5) . Sec and Tat pathways are conserved in the thylakoid membranes of chloroplasts where they mediate protein transport into the thylakoid lumen (6) .
In bacteria the Tat pathway is important in diverse processes including energy metabolism, formation of the cell envelope, and nutrient acquisition (2, 7) . The Tat system is also normally required for the virulence of bacterial pathogens (8) . In plants the Tat pathway plays an essential role in the biogenesis of the photosynthetic electron transport chain (9) .
The Tat system of Escherichia coli comprises the integral membrane proteins TatA, TatB, TatC, and TatE (10) (11) (12) (13) . TatA and TatE are homologous and functionally equivalent proteins (10) . However, TatA expression is 50-fold higher than that of TatE, and so TatA is thought to be the dominant contributor to Tat function under physiological conditions (14) .
Proteins are targeted to the Tat pathway by N-terminal signal peptides containing a consensus amino acid sequence motif that includes two consecutive arginine residues (15) (16) (17) . Tat-signal peptides are recognized at the membrane by a TatBC receptor complex (18) (19) (20) (21) (22) (23) . Substrate protein binding to TatBC causes a PMF-dependent recruitment of TatA (and presumably TatE) to assemble the active translocation site (18, 24) . Within the resultant TatABC complex, TatA is proposed to provide the pathway for substrate movement across the membrane bilayer (24) . The association of TatA with TatBC is reversed when substrate is no longer available (24) .
TatA recruitment to the TatBC-substrate complex is associated with a significant increase in the number of chemical crosslinks that can be formed between TatA molecules, indicating that TatA undergoes a major structural reorganization in the translocation complex (25, 26) . One possible interpretation of this reorganization is that TatA undergoes substrate-induced association. Such a model would solve the problem of maintaining the membrane permeability barrier between transport events because the TatA transporter element would be assembled only when a substrate protein is available. Substrateinduced association of TatA protomers could allow stepwise construction of a channel-like element around the substrate until the required size for transport is achieved (27) . Alternatively, concentrating TatA might perturb the local membrane structure to allow substrate movement (25, (28) (29) (30) . It also is possible that formation of a TatA oligomer stores conformational energy that is then used to drive the substrate across the membrane.
Despite the appeal of the substrate-induced TatA association model, cross-linking alone cannot demonstrate that the TatA
Significance
The twin-arginine translocation (Tat) pathway transports folded proteins across a membrane without significant ion leakage. The mechanism by which Tat is able to carry out this challenging feat is unclear. We used direct imaging of fluorescent protein-tagged Tat components in bacterial cells to show that the TatA element of the Tat system undergoes substrate-and proton motive force-dependent oligomerization. Thus the Tat transporter element is assembled on demand, avoiding the need to seal the transporter between translocation events. reorganization corresponds to TatA assembly rather than to TatA conformational change. To address this issue, we previously undertook direct imaging of YFP-labeled TatA (TatA-YFP) that had been expressed at native levels in living E. coli cells (31). Individual TatA complexes could be tracked by videorate fluorescence microscopy, and their oligomeric state could be estimated from their photobleaching traces. This analysis indicated that TatA forms complexes of variable stoichiometry with a median size of 25 polypeptides. In the absence of TatBC, only small TatA oligomers were found (median size, four polypeptides). This observation is consistent with the prediction from the substrate-induced TatA association model that substratebound TatBC mediates TatA assembly. However, no influence of substrate or PMF on the TatA oligomeric state was detected. Furthermore, the TatA-YFP fusions used in these experiments supported only trace transport activity, raising the question of the physiological relevance of our observations.
Here we show that TatA-YFP fusions are able to support efficient Tat transport in the presence of the TatA paralogue TatE. Using this experimental system, we demonstrate that formation of TatA complexes depends on the presence of substrate protein, the TatBC complex, and the PMF. These observations provide direct evidence for key tenets of the substrate-induced TatAassociation model. Our data also indicate that disassembly of the TatA complex is a PMF-independent process.
Results

Coexpression with TatE Improves the Transport Activity of Cells
Expressing TatA-YFP. Our previous studies using fluorescence microscopy to visualize TatA in E. coli cells suffered from the significant limitation that TatA-fluorescent protein fusions support only very low levels of Tat transport and so may not be accurate reporters of the behavior of native TatA (31). In an attempt to overcome this problem, we explored whether a TatA-YFP fusion protein could be integrated into a well-functioning Tat transport pathway by coexpression with either the native TatA protein or with the TatA paralogue TatE.
We constructed E. coli strains in which a gene coding for a TatA-YFP fusion was placed under the control of the native tatA promoter and then integrated into the chromosome at the phage lambda attachment site (att) in a range of tat backgrounds (Table S1 ). The TatA and YFP domains of the fusion are separated by a rigid linker sequence (32), and the YFP domain contains the dimerization-suppressing A206K substitution (33). The resulting strains are referred to according to the Tat proteins they produce, with "Ay" being the TatA-YFP fusion (Table  S1 ). Thus, "AyBCE" indicates a strain lacking the native TatA protein but expressing the TatA-YFP fusion as well as TatB, TatC, and TatE.
We assessed the ability of TatA-YFP to interact functionally with TatA or TatE by examining anaerobic respiration with trimethylamine N-oxide (TMAO) as electron acceptor. This metabolism requires the Tat-dependent periplasmic enzymes TMAO reductase and dimethyl sulfoxide reductase. A strain in which all tat genes have been deleted (Δtat) shows greatly reduced growth rate and cell yield relative to the parental strain (ABCE) when cultured anoxically on LB/TMAO/glycerol medium (Fig. 1A) . It also exhibits drastically reduced periplasmic TMAO reductase activity (Fig. 1B) . The same phenotype is seen in a strain missing only the genes for tatA and tatE (strain BC; Fig. 1 A and B) . Deletion of tatE alone did not impair Tat activity in these assays (strain ABC; Fig. 1 A and B) , but deletion of only tatA resulted in a significant, but incomplete, reduction in Tat functionality (strain BCE; Fig. 1 A and B) . Thus, as in earlier studies (10) , either tatA or tatE can sustain Tat transport, but tatE supports a considerably lower level of Tat activity than tatA, most likely because of the very low level of tatE expression (14) .
The TatA-YFP fusion was unable to restore Tat transport activity to a strain lacking both the native TatA and TatE proteins (strain AyBC; Fig. 1 A and B) . If the TatA-YFP fusion was introduced into cells expressing TatA but not TatE (strain AAyBC), the strain exhibited slightly faster growth than the parental ABCE strain on LB/TMAO/glycerol medium (Fig. 1A) . This observation shows that the TatA-YFP fusion does not interfere with wild-type TatA function. It also hints at a synergistic interaction between the two proteins. Crucially, when the TatA-YFP fusion was introduced into a background that produces TatE but not TatA (strain AyBCE), there was a clear enhancement of Tat transport, with the TatA-YFP fusion restoring transport activity to approximately wild-type levels ( Fig. 1 A and  B) . Thus, although the TatA-YFP fusion is unable to sustain Tat transport by itself, it is able to augment the transport activity of a TatE-producing strain. Therefore transport activity in the AyBCE strain can be ascribed directly to the presence of TatA-YFP demonstrating that the fluorescent reporter protein is being incorporated into active translocation sites.
In summary, coexpression of TatA-YFP with either native TatA or TatE produces strains that are able to carry out physiological Tat transport. However, only in the strain coexpressing TatE is it certain that the fusion protein contributes to the activity of the pathway. For this reason we chose the strain coexpressing TatE to study the oligomeric state of TatA in an active Tat transport system. We have, however, confirmed our key observations with the strain coexpressing TatA (see below).
We verified that the TatA-YFP fusion in the strain coexpressing TatE (AyBCE) is stable and localized in the membrane fraction of broken cells (Fig. 1C) . Coexpression of TatE was found to increase the level of TatA-YFP in the cells even though there is no change in the genomic context of the fusion-coding gene. We excluded the possibility that enhanced levels of TatA-YFP were responsible for the increased transport activity of this strain by showing that overproduced TatA-YFP does not support Tat transport in the absence of TatE (Fig. S1) . Fluorescence Imaging of TatA-YFP in a Transport-Active Background.
We used fluorescence microscopy to determine the effects of TatE coexpression on the oligomerization of the TatA-YFP fusion. In the absence of TatE the TatA-YFP fusion is located predominantly in bright, independently mobile foci that exhibit no preferred localization within the cell membrane (strain AyBC; Fig. 2A ). Our earlier analysis of TatA-YFP foci in the same genetic background showed that the foci correspond to complexes containing tens of copies of the fusion protein (31). Coexpression with TatE caused a striking redistribution of fluorescence with the majority of the fluorescent proteins now present as a dispersed halo around the periphery of the cell with only occasional bright foci (strain AyBCE; Fig. 2A and Movie S1). Fluorescence of the membrane-associated TatA-YFP protein appears as a halo at the cell periphery due to the imaging geometry. At higher time resolution this halo is resolved as numerous, dim, fast-moving foci (Movie S2). Fluorescent halos were also seen if TatA-YFP was coexpressed with TatA instead of TatE (strain AAyBC; Fig. 2A ). For convenience we will term the bright foci as TatA "assemblies" and the halos as "dispersed" TatA.
We developed an automated classification routine to determine the number of bright foci in individual cells (SI Materials and Methods). Across a population of cells this analysis confirmed that strain AyBC has a significantly higher number of foci (i.e., TatA assemblies) per cell than either strain AyBCE or AAyBC (Fig. 2 B and C) .
The oligomeric states of the TatA-YFP fusion proteins observed in transport-active cells can by interpreted using a simple model based on the TatA association hypothesis (Fig. 2D ). In this model TatA can be in two interconverting states, either dispersed in the membrane or assembled with TatBC to form an active translocation site. TatA association is induced by substrate binding to TatBC in the presence of a PMF, whereas TatA dissociation occurs when substrate is no longer bound to the translocation complex. Our imaging experiments determine the steady-state distribution of TatA between the two states. This distribution depends on the relative rates of the TatA association and dissociation processes, which are influenced both by the availability of substrate to initiate TatA assembly events and by the rate of substrate removal from the translocation site by transport to trigger TatA dispersion.
In the AyBCE strain TatA-YFP is found predominantly in the dispersed state. The levels of endogenous Tat substrates in aerobically grown cells are expected to be low (14) , resulting in a limited frequency of initiation of TatA assembly. At the same time, the Tat transport activity of this strain is high, leading to efficient completion of transport. Thus, the cells have excess transport capacity, and those sites that do assemble move rapidly through the transport cycle, releasing the translocated substrate and returning TatA-YFP to the dispersed membrane pool. The net result is that at any given time only a small proportion of the TatA-YFP present in the cell is part of an assembled translocation site.
By contrast, TatA-YFP accumulates in the assembled state in the absence of TatE (strain AyBC). This behavior can be explained by the low transport activity of this strain, because in our model slowing transport retards the release of the substrate protein from the translocation site and delays TatA dissociation.
Tat Substrates Induce TatA Association. Our model predicts that an increase in the availability of substrate in strain AyBCE should increase the rate of TatA association and thereby increase the proportion of TatA-YFP molecules in the assembled state. Consistent with this hypothesis, overproduction of the E. coli Tat substrate CueO (34) from a plasmid caused a shift in the distribution of TatA-YFP from a diffuse to a punctate pattern ( Fig.  3A and Movie S3). This effect requires a functional signal peptide, because no induction of spot formation was seen if the essential twin arginine residues of the CueO signal peptide were conservatively substituted with lysine residues (CueO KK ) (Fig.  3A) . Frequency analysis of the number of foci per cell shows a significant difference between the population of cells expressing CueO and the populations of cells that either do not overproduce CueO or that express the transport-inactive variant (Fig.  3B) . Cell fractionation and immunoblotting demonstrated that the wild-type and variant CueO proteins were present at similar levels in these experiments and confirmed that only the wild-type protein was transported to the periplasm and underwent signal peptide cleavage (Fig. 3C) . Substrate-dependent TatA-YFP association was also seen when an alternative Tat substrate, the Acidithiobacillus ferrooxidans high-potential iron-sulfur protein (HiPIP) (35), was overproduced and TatA association was again dependent on a functional signal peptide ( Fig. 3 A-C) . Substrate-dependent TatA-YFP association was also observed if TatA-YFP was coexpressed with TatA instead of TatE (Fig. S2) . Thus, TatA association is a generic response to the presence of transport-competent substrate proteins.
To further test the causal relationship between substrate expression and TatA-YFP association, we immobilized cells containing the CueO expression plasmid on a microscope slide and took time-lapse images after treatment with isopropyl β-d-1-thiogalactopyranoside (IPTG) to induce CueO expression. Over a time course of minutes the distribution of TatA-YFP changed from diffuse to punctate (Fig. 3D) . Immunoblotting of the same strain after induction of CueO expression shows that TatA-YFP association is correlated with an increase in cellular CueO concentration (Fig. 3E ).
TatA-YFP Association Requires TatBC. The substrate-induced TatAassociation model predicts that substrate binding to the TatBC complex is required to form TatA assemblies (Fig. 2D ). In agreement with this prediction, removal of TatB and TatC prevented formation of TatA-YFP assemblies even in the presence of overproduced CueO substrate ( Fig. 4 A and B) . However, substrate-induced TatA-YFP assemblies could be recovered when both TatBC and CueO were expressed from plasmids in this strain ( Fig. 4 A and B) . When examining the images in Fig. 4A , note that strains with a complete defect in Tat transport exhibit a cell-chaining phenotype because of the mislocalization of two periplasmic amidases (36, 37).
To confirm that TatA-YFP association was the result of a productive interaction between substrate proteins and TatBC, we expressed both CueO and TatBC from plasmids in strain AyE, but this time we used a TatC variant containing the substitutions F94A and E103A that are known to block signal peptide binding (21, 38) . These cells failed to produce TatA-YFP assemblies, demonstrating that TatBC must be capable of binding substrate proteins for TatA association to occur (Fig. 4 A and B) . Immunoblotting confirmed that TatB and the TatC variant had been successfully expressed in this experiment (Fig. 4C ).
Essential TatA Residue Phe39 Is Not Required for TatA Association.
The structure of E. coli TatA consists of a transmembrane helix followed by an amphipathic helix and then a natively unstructured tail (30). Phenylalanine 39 at the end of the amphipathic helix is invariant and essential for TatA function (39, 40). We confirmed that a TatA F39A variant is transport inactive when expressed from the chromosome under the control of the native tatA promoter (Fig. 5A , strain A F39A BC). However, in contrast to the dominant-negative phenotype reported for the TatA F39A variant when expressed from a multicopy plasmid (39, 40), the chromosomally expressed TatA F39A variant did not affect the activity of wild-type TatA or TatE proteins (strains AA F39A BC and A F39A BCE; Fig. 5A ). The F39A substitution was also found to be inactivating when introduced into TatA-YFP as the resulting protein was unable to augment the Tat activity of a strain expressing TatE (strain Ay F39A BCE; Fig. 5A ). Fluorescence imaging of this strain showed that TatA assemblies were present even without overproduction of a substrate protein (strain Ay The presence of TatA-YFP assemblies in strain Ay F39A BCE indicates that the inactivating F39A substitution does not prevent TatA association but inhibits a later step in Tat transport.
TatA Association, but Not Dissociation, Requires the PMF. Protein transport by the Tat system is energized by the transmembrane PMF (4, 5) . To explore whether the oligomeric state of TatA-YFP is sensitive to the PMF, we used the protonophore carbonyl cyanide-m-chlorophenyl hydrazine (CCCP) to dissipate the cytoplasmic membrane PMF of AyBCE cells expressing either CueO or HiPIP (Fig. 6 A and C) . With either substrate protein the steady-state distribution of TatA-YFP shifts from the assembled to the dispersed form after the addition of the protonophore. This change was reversible, because subsequent treatment with β-mercaptoethanol to inactivate CCCP led to the reappearance of TatA-YFP assemblies at pre-CCCP levels ( Fig.  6 A and C) . This last observation shows that the PMF is required for TatA complex assembly, as predicted by the substrate-induced TatA association model.
It has been inferred previously that completion of Tat transport requires a membrane potential (Δψ) that is below the detection limit of indicator dyes (41). We considered that cells treated with CCCP and exhibiting TatA-YFP dispersion might retain an unmeasurable Δψ of this magnitude. However, we also observed TatA-YFP disassembly with cells that had been treated with the ionophores valinomycin and nigericin in the presence of potassium ions (Fig. 6 B and C) . This combination dissipates both the Δψ and ΔpH components of the PMF and is reported to block completion of Tat transport at low Δψ (41). TatA-YFP assemblies were likewise dispersed by addition of the poreforming colicin E1, which depolarizes the E. coli cytoplasmic membrane ( Fig. 6 B and C) (42) . Thus, TatA-YFP disassembly can occur in the absence of a Δψ.
To investigate the timescale of TatA-YFP complex association and dissociation, we took time-lapse images of a single cell as it was treated successively with CCCP and then with β-mercaptoethanol (Fig. 6D ). Dissociation and reassociation of TatA-YFP complexes occurred within 1 min of the addition of CCCP or β-mercaptoethanol, respectively. We analyzed the disassembly and assembly processes with higher time resolution and found that TatA-YFP complexes dissociate within 5-15 s after CCCP is added and reform within 20-120 s after β-mercaptoethanol is added. Representative experiments are shown in A different response to protonophore addition was observed in strains that assemble TatA-YFP but do not support significant Tat transport activity. When strain AyBC was treated with CCCP, no dissociation of TatA complexes was observed (Fig. 6 G and H) . (Fig. 6 G and H) and were significantly more abundant than in strains with dispersed TatA-YFP such as AyBCE. Thus, TatA complex disassembly is correlated with an active Tat system.
TatB-YFP and TatC-YFP Form Oligomers That Are Unaffected by
Substrate Concentration or the PMF. Having established that TatA undergoes changes in oligomerization state, we investigated whether other Tat components also show such changes under similar conditions. We generated strains expressing either TatB-YFP or TatC-YFP by inserting an operon carrying tatA-tatByfptatC or tatA-tatB-tatCyfp at the att site of a ΔtatABCΔtatE strain. Although immunoblotting of cell membranes showed that strain AByC had nearly wild-type levels of all three Tat proteins, the three Tat proteins were present at low or undetectable levels in strain ABCy, possibly because of mRNA instability (Fig. S3A) . To overcome this problem, we constructed low-copy-number plasmids that permit the expression of either TatB-YFP or TatC-YFP at nearly native levels (Fig. S3A) . The AByC strain and the plasmids expressing TatB-YFP and TatC-YFP fusions all supported full transport activity as assessed by anaerobic growth on LB/glycerol/ TMAO medium (Fig. S3B) .
TatB-YFP and TatC-YFP both exhibited multiple, mobile fluorescent foci when plasmid-expressed in the presence of the other three Tat components ( Fig. 7 A and C and Movies S6 and S7) or when chromosomally expressed in strain AByC (Fig. S3C) . No significant change in the fluorescence distribution of either fusion was found after overproduction of the substrate protein CueO or upon the addition of the protonophore CCCP (Fig. 7) . Taken together, these data show that the oligomeric states of TatB and TatC do not change under conditions that lead to TatA complex assembly or disassembly.
TatC-YFP was still able to oligomerize in the absence of TatB (strain AE pCy; Fig. 7 C and D) . By contrast, cells expressing TatB-YFP without TatC showed a clear shift to a more dispersed pattern of fluorescence, indicating that TatB oligomerization requires TatC (strain AE pBy; Fig. 7 A and B) .
Discussion
TatA-fluorescent protein fusions are unable to functionally substitute for the wild-type TatA protein (31), and this limitation has made it difficult to use fluorescence-based methods to probe TatA behavior. We now show that a TatA-YFP fusion can be made to support physiological Tat transport activity in E. coli by expression alongside the endogenous TatA paralogue TatE. We have used this experimental system to test the substrate-induced TatA association model in the context of a functional Tat system.
For TatA-YFP to be a useful reporter of TatA behavior, the fusion protein must be incorporated into active translocation sites. Our data strongly suggest this incorporation occurs, because the otherwise inactive TatA-YFP fusion markedly enhances the Tat transport activity supported by TatE. The changes in Tat-YFP oligomer state seen in response to transport-relevant perturbations were the same whether Tat-YFP had been coexpressed with native TatA or TatE. This observation indicates that it is the absence of a fusion domain, and not some special feature of TatE, that allows functional cooperation with TatA-YFP. More specifically, because TatA-YFP expressed without TatA or TatE is unable to sustain transport but still forms large assemblies, we can infer that the YFP domain interferes with a step in Tat transport that occurs only after TatA association.
The substrate-induced TatA-YFP assemblies observed in the presence of TatE probably contain only a very small proportion of TatE protomers because of the low level of TatE expression relative to TatA expression (14) (indeed, the TatE concentration present in our experiments is observed to be transport limiting; Fig. 1 A and B) . A low TatE:TatA-YFP ratio suggests that TatA-YFP can be functionally tolerated at most, but not all, positions within the assembled TatA complex. This notion in turn raises the possibility that TatA is present in at least two different structural environments within the active translocation site. A plausible scenario would have a limited number of TatA protomers in intimate contact with the TatBC complex, nucleating the oligomerization of the bulk of the TatA subunits into a structure extending out into the surrounding phospholipid bilayer. In this model TatA-YFP fusions are able to function at the "bulk" but not at the "intimate" positions. Such a model would be consistent with observations that some TatA molecules associate with the resting TatBC complex in E. coli as judged by site-specific photoaffinity cross-linking (43), FRET studies (44), or copur- ification (45-47). As an alternative, a limited number of TatE protomers interdigitated among the TatA-YFP subunits may provide sufficient conformational flexibility to relieve the steric effects of the YFP domains.
Our imaging experiments capture the steady-state distribution of TatA-YFP between large assemblies and a pool of small units. When only endogenous levels of substrate proteins are present, the TatA assemblies are rare. However, when substrate proteins are overproduced, the number of TatA assemblies present in the cell increases dramatically, as expected if TatA association is triggered by substrate availability. This phenomenon is likely to be general, because it was seen with the two very different substrates, CueO, a large native E. coli Tat substrate (5-6 nm in diameter) that acquires copper ion cofactors in the periplasm, and A. ferrooxidans HiPIP, a small heterologous Tat substrate (2.5-3 nm in diameter) that has an iron-sulfur cluster inserted in the cytoplasm before transport.
Induction of TatA assembly required the substrate protein to have a functional Tat signal peptide, showing that formation of TatA complexes is a consequence of a specific interaction of the substrate with the Tat system. Complex formation was also absolutely dependent upon the presence of TatBC, as expected if TatA is assembled by a substrate-activated TatBC complex. Importantly, TatA association requires the TatBC complex to be competent for substrate binding, excluding the possibility that TatBC is a passive scaffold with which TatA is permanently associated.
A key feature of the substrate-induced TatA association model is that the formation of TatA complexes is driven by the transmembrane PMF, as indeed we observed in our transport-active experimental system. Specifically, we found that TatA assemblies reform upon restoration of the PMF to previously de-energized cells. In the presence of inducing levels of substrate, the TatA assemblies were rebuilt in as little as 20 s, suggesting that PMFdriven TatA association is sufficiently fast to be part of the Tat transport mechanism. The kinetics of TatA complex formation after the induction of substrate overproduction were considerably slower (ca. 20 min to completion) than those observed in the PMF restoration experiment. This difference indicates that it requires a significant period after induction for the substrate to reach a concentration that affects the steady-state level of TatA complexes present.
We found that TatA-YFP assemblies dissociate rapidly upon dissipation of the PMF even though substrate molecules are still present. A possible interpretation of this observation is that the oligomer equilibrium is strongly biased in favor of the assembled state when substrate and a PMF are both present, but that with removal of the PMF the direction of this equilibrium is reversed, leading to dissociation of TatA oligomers. However, the situation is more complex than this, because TatA assemblies are able to persist in the absence of a PMF in strains that can assemble TatA but are incompetent for transport (strains AyBC and Ay F39A BCE), showing that it is possible for TatA oligomers to reach a state that is stable to removal of the PMF. Although it is conceivable that the TatA-YFP oligomers in these transportincompetent strains experience a nonphysiological stabilization against reversal of assembly, such an enhancement of subunit interactions within the oligomer would be a surprising consequence of the removal of a mechanistically important component or residue. Instead, these strains are most likely to be defective in catalyzing a transport step that takes place after TatA assembly. If so, our observations can be explained by suggesting that there is a critical stage in TatA assembly at which TatA oligomerization becomes irreversible. Such a critical point could correspond, for example, to closure of a TatA ring or to a conformational change associated with completion of TatA assembly. Only on release of the substrate protein through transport is the TatABC complex able to re-enter a state in which TatA oligomerization changes (i.e., disassembly) are again possible. Because the transport-inactive strains are unable to expel the bound substrate protein by translocation, they accumulate TatA-YFP in the PMF-insensitive assembled state. This model is set out in Fig. 8 .
Because a PMF will always be present in living cells, substrate availability controls the direction of the TatA assembly/disassembly process. When substrate proteins are scarce, each transport event will be associated with a complete cycle of TatA assembly and disassembly. However, during transport at high substrate concentrations, binding of the next substrate molecule to the TatBC complex might occur before TatA dissociation has started or before it has been fully completed. Under these conditions it is implicit in our model that TatA sites can be reused, as recently suggested (20) , or regenerated from a partially disassembled state by reversing the direction of the disassembly equilibrium upon substrate binding (Fig. 8) . Similar considerations apply if multiple substrate-binding sites within the TatBC complex are able to access the same TatA assembly (20, 48) .
In contrast to TatA, we find that the oligomeric states of both TatB and TatC are unaffected by either raising substrate concentrations or dissipating the PMF. This finding is consistent with previous observations that these two proteins copurify in detergent solution as a large TatBC complex and that the size and composition of the complex are not significantly altered by substrate binding (19, 22, 45, 49, 50) . It is also consistent with the observation that TatBC complexes do not exhibit the exchange of TatC subunits that would be expected if TatC undergoes assembly cycles (23) . We find that the TatB protein has a lower oligomer state if TatC is absent but that TatC oligomerization is independent of TatB. These observations are compatible with the previous characterization of these proteins in detergent solution where, in the absence of a partner protein, TatC still forms a distinct multimeric complex but TatB is reported to be in small or heterogeneous oligomers (49, 50).
In summary, our TatA imaging experiments in E. coli verify the key predictions of the substrate-induced TatA association model that was derived from cross-linking experiments in plant thylakoids: that TatA can exist in both dispersed and high olig- This process is driven in the forward direction by the transmembrane PMF. At a critical stage in the assembly process the TatABC-substrate assembly enters a metastable state (indicated by square brackets) from which it can be released only by the transport of the substrate protein. The TatABC complex without bound substrate is unstable, and TatA disassembles. Under conditions of high substrate availability it is possible that a new substrate molecule will be bound to the TatBC complex before TatA is able to dissociate. In this case the TatABC site could be either reused directly or recycled from a partially disassembled complex (dotted arrows). Experimental perturbations of the system are shown in red. Dissipation of the PMF (− PMF) reverses the direction of TatA assembly. Transport-defective strains AyBC and Ay F39A BCE still can assemble TatA, are insensitive to the removal of the PMF, and are inferred to have a defect in progression from the metastable state. The number of steps shown for the TatA oligomerization processes and the number of TatA subunits and TatBC units in the assembled TatABC complexes are arbitrary and were selected for illustrative convenience.
omer states; that the number of TatA assemblies is a function of substrate availability; that TatA association requires the substrate to be able to bind to the TatBC complex; and that TatA association occurs only in the presence of the transmembrane PMF. Our experiments extend the TatA association model by suggesting that transport requires progression through distinct assembled states that can be distinguished by their sensitivity to removal of the PMF.
Materials and Methods
Strain Construction, Cell Growth and Analytical Methods. Construction of plasmids and strains, preparation of cells for microscopy, and analytical methods are described in SI Materials and Methods. The plasmids and strains used in this work are listed in Tables S1 and S2 .
Fluorescence Microscopy. Cells were imaged using an inverted microscope (Ti-E; Nikon) illuminated by a 532-nm DPSS Nd:YAG laser (Compass 215M; Coherent Inc). The excitation light was focused at the back aperture of an oil immersion objective lens (100× Plan Apo N.A. 1.4; Nikon) to provide glancing illumination of the coverslip surface as in HiLo or pseudo total internal reflection fluorescence imaging (51, 52). Typically, HiLo imaging illuminates a sample to a depth of 5 μm but offers improved signal as compared with absolute epifluorescence (52). The power entering the back of the objective was 2 mW, resulting in a power density in the image plane of 25 μW·μm
Emitted fluorescence was collected through the same objective and was transmitted through dichroic (C67195; Nikon) and emission (BrightLine 582/ 75; Semrock) filters. Images were recorded using an EMCCD camera with exposure times between 4 and 20 ms (iXon+ DV860E; Andor Technology). For figure composition, image stacks were imported into MATLAB (MathWorks). Image stacks averaged over 40 ms were scaled to display 1,500 arbitrary units (a.u.) as the minimum (black) and 7,500 a.u. as the maximum (white) unless otherwise noted and were exported as JPEG files. For time-lapse imaging, the power entering the back of the objective was 0.04 mW (power density 0.5 μW·μm ) (Fig. 6 D-F) , and each image is a single exposure (200 ms for Fig. 3D ; 20 ms for Fig. 6 C, E, and F).
Automated Spot
Counting. An algorithm was devised to discriminate effectively between TatA-YFP present as quickly moving, dim, diffuse spots and the slower-moving but bright foci observed upon Tat activation. By averaging together frames in our image sequence, we trade time resolution for an improved signal-to-noise ratio. In doing so, the fast-moving diffuse background no longer appears as individual, poorly resolved spots but as a diffuse halo at the cell periphery. This method provides clear discrimination between the two populations and forms the basis of our algorithm.
Image stacks in MATLAB were averaged to create a single image with an improved signal-to-noise ratio for spot counting. Stacks were averaged over 40 ms to provide optimal discrimination between the diffuse halo and TatA foci. Images were rejected from further analysis if the mean pixel brightness over the entire image was below the background noise (1,000 a.u.) or if the mean cell pixel brightness exceeded 16,000 a.u. (saturated cell image).
Spot counting then involved three successive stages: identification of cells; identification of bright features; and removal of bright features that do not correspond to spots plus deconvolution of overlapping spots. A rectangular region of interest comprising a single cell was selected manually for each image. Cell masks were identified inside the region of interest by thresholding the image to locate all pixels 0.8 times brighter than the mean pixel intensity across the region of interest. Then a spot-counting algorithm was applied to the masked cell. The algorithm had the following elements. (i) For TatA-YFP and TatB-YFP, contours of intensity were mapped for the cell at intervals of 500 a.u. in the range 1,500-7,500 a.u. This range covered the brightness range of the majority of spots over all Ay strains and conditions. For TatC-YFP, contours were mapped at intervals of 250 a.u. in the range of 1,250-7,500 a.u. (ii) At each intensity contour the number of discrete regions was counted. Each region was designated as a spot if it was larger in area than 3 × 3 pixels, smaller in area than 120 × 120 pixels, and had a maximum eccentricity of 0.6 where eccentricity was defined as the ratio of the major axis to the minor axis of the ellipse that encompassed the spot region. (iii) At the contour for which the greatest number of spots satisfying these criteria was counted, individual spots were reanalyzed to determine whether the region resolved into multiple regions as the density of contours was increased. For this purpose, only the region of the initial spot was considered, and the contour levels were increased incrementally (by 500 a.u. for TatA-YFP and TatB-YFP and by 250 a.u. for TatC-YFP) to see if each single spot was resolved into two smaller spots at a higher contour intensity, or if it remained a single spot throughout. (iv) The total number of regions determined by this approach then was counted and returned as the spot count for that individual cell. Histograms showing the population distributions of number of intense spots per cell are given in Fig. 2B and Fig. S4 .
Comparisons between the distributions of the number of spots under different experimental conditions were made using a Welch's t test in R (53).
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To create a chromosomal deletion of tatABC (MΔABC-A), the apramycin-resistant ΔtatABC::apra r allele from strain BIF030 (1) was transferred to strain MC4100-A (2) by P1-mediated transduction using standard protocols (3). To create a chromosomal deletion of tatBC (MΔBC), a tatBC deletion allele was assembled by digesting plasmid pFAT23 (4) with ClaI and KpnI to release the downstream part of the tatC deletion allele and then cloning this fragment into pFAT164 containing an analogously assembled tatB deletion allele (5) that had been digested with the same enzymes. The resultant tatBC deletion allele was released by digestion with XbaI and KpnI and was cloned into similarly digested pMAK705 (6) . The ΔtatBC allele subsequently was moved onto the chromosome of MC4100 as described previously (6) .
All insertions into the E. coli phage lambda attachment site (att) were delivered using plasmid pRS552 (7) .
The cassette P tatA -tatA-EAK-eyfp A206K was used to construct Ay strains. tatA was amplified from pUNITAT2 (8) with primers TATAPROM1 (5′-GCGCGAATTCTGTCGGTTGGCGCAAA-ACACGCTG-3′) and TatANostopREV (5′-GCGCGGATCCG-TATGCATCACCTGCTCTTTATCGTGGCGCTTC-3′) and was cloned into pBluescript KS (Stratagene) digested with the same enzymes to create pTatANsiINOSTOP. DNA encoding an α-helical linker [amino acid sequence (EAAAK) 8 AAA] (9) was synthesized (Genscript) with an NsiI site at the 5′ end and a BsiWI site followed by a BamHI site at the 3′ end. The linker was excised with NsiI and BamHI and then was cloned into pTatANsiINOSTOP digested with the same enzymes to produce pTatAlinker. The dimerization-suppressing substitution A206K (10) was introduced into the EYFP-coding gene using Quikchange mutagenesis (Stratagene) of plasmid pYFP1 (11) and primers A206KF (5′-CTAC-CTGAGCTACCAGTCCAAGC TGAGCAAAGACCCCAAC-3′) and A206KR (5′-GTTGGGGTCTTTGCTCAGCTTGGACTG-GTAGCTCAGGTAG-3′), resulting in plasmid pYFPA206K. The resulting eyfp A206K allele was amplified using primers EYFPBsiFOR (5′-GCGCCGTACGGTGAGCAAGGGCGAGGAG-3′) and EYFPBamREV (5′-GCGCGGATCCTTACTTGTACAGCTCGTC-3′); then the product was digested with BsiWI and BamHI, and was cloned into pTatAlinker digested with the same enzymes to produce pBSTatAry. This plasmid then was digested with EcoRI and BamHI, and the released P tatA -tatA-EAK-eyfp A206K cassette was cloned into the same sites in pRS552 to allow integration into the E. coli chromosome.
For Ay F39A strains the phe39ala mutation was introduced into tatA-EAK-yfp in plasmid pBSTatAry by site-directed mutagenesis using primers TatAF39AF (5′-GGTGCGTCGATCAAAGG-CGCTAAAAAAGCAATGAGCGATG-3′) and TatAF39AR (5′-CATCGCTCATTGCTTTTTTAGCGCCTTTGATCGACG-CACC-3′). An EcoRI-BamHI fragment encompassing P tatA -tatA-EAK-eyfp F39A then was subcloned into pRS552 for delivery onto the chromosome.
For A F39A strains the phe39ala mutation was introduced into tatA in plasmid pKSUniA (12) using primers TatAF39AF and TatAF39AR. An EcoRI-BamHI fragment encompassing P tatAtatA F39A was then was subcloned into pRS552 for delivery onto the chromosome.
To construct strain DADE-λAByC, the tatB gene was amplified from pUNITAT2 with primers TatBFOR (5′-GCGCGA-ATTCCACGTGTTTGATATCGGTTTTAGCG-3′) and TatBNostopREV (5′-GCGCGGATCCCGTACGCGGTTTATCAC-TCGACGAAG-3′). The product was digested with EcoRI and BamHI and was cloned into pBluescript KS to form pTatBNostop. The eyfp A206K allele was amplified from pYFPA206K with primers EYFPBsiFOR (5′-GCGCCGTACGGTGAGCAAGG-GCG AGGAG-3′) and TatBYFPREV (5′-GCGCGGATCCC-TTAAGGTTTATCACTCG ATTACTTGTACAGCTCGTCC-ATGC-3′); then the product was digested with BsiI and BamHI and was cloned into the same sites in pTatBNoStop to produce plasmid pTatB-YFP. To maintain the genetic context, the last six codons of tatB in this plasmid (including the stop codon) are fused to the C terminus of eyfp A206K . The tatB-eyfp A206K fusion was then excised from plasmid pTatB-YFP with PmlI and AflII and was subcloned into the same sites in pSKUnitatABC (13) . The entire P tatA -tatAB-eyfp A206K -C construct was then excised with EcoRI and BamHI and was cloned into the same sites in pRS552. The resultant construct was integrated onto the chromosome of strain DADE (MC4100 ΔtatABCDE) (14) .
To construct DADE-λABCy, tatC was amplified from pUNI-TAT with primers TatCFOR (5′-GCGCGAATTCCTTAAG-CATGTCTGTAGAAGATAC-3′) and TatCBamREV (5′-GC-GCGGATCCCGTAGCTTCTTCAGTTTTTTCGCTTTCTGC-3′); the product was digested with EcoRI and BamHI and was cloned into pBluescript SK and was digested with the same enzymes to produce pTatCNoSTOP. eyfp A206K was then amplified from pYFPA206K with primers EYFPBsiFOR and EYFPBam-REV and was cloned into pTatCNoSTOP using BsiWI and BamHI digestion to produce pTatC-YFP. The tatC-eyfp A206K allele was then excised with BsiWI and BamHI and was cloned into pSKUnitatABC to produce pTatABCyfp. Finally, the entire insert was subcloned into pRS552 using BamHI and EcoRI to give p552ABCy. p552ABCy was used for integration of P tatA -tatABCeyfp A206k into the chromosome of strain DADE.
To verify the construction of att-directed integrant strains, the tat and att loci were amplified from genomic DNA using primers UbiBdown (5′-TCTGATCGCCTGGTTTGTC-3′) and SphITatCR (5′-CCCGCATGCTTATTCTTCAGTTTTTTCGC-3′) or 552F (5′-TAAACTGCCAGGAATTG-3′) and 5522R (5′-GATTAA GTTGGGTAACGCC-3′), respectively, and were sequenced.
Plasmid Construction. The plasmids used in this work are listed in Table S2 .
pQE-CueO kk h was created by site-directed mutagenesis of pQE80-CueO (11) with primers CueOKKF (5′-GAATAAGG-AAATAACTATGCAAAAGAAGGATTTCTTAAAATATTC-CGTCG-3′) and CueOKKR (5′-CGACGGAATATTTTAAG-AAATCCTTCTT TTGCATAGTTATTTCCTTATTC-3′). For pQE-HiPIPh, the HiPIP-coding gene from Acidithiobacillus ferrooxidans together with its ribosome binding site and lacking its stop codon was amplified from plasmid pET21-iro 33020 (15) with primers HipipEco (5′-GCGCGAATTCGAAGGAGCGA-TATCATGAGTGAGAAACTGAAGG-3′) and HipipBgl (5′-GCGCAGATCTTGCGGGCATCGGCGTGAACG-3′) and was cloned into pQE-60 (Qiagen) as an EcoRI-BglII fragment. This fragment was then excised by digestion with NheI-XhoI and was cloned into pQE-80 (Qiagen) digested with the same enzymes. pQE-HiPIP KK h was created from pQE-HiPIPh by site-directed mutagenesis with primers HiPIPKKF (5′-CAAGGCTGGGAA-CATAAGCAAGAAGGACATGTTGAAAGGTATCG-3′) and HiPIPKKR (5′-CGATACCTTTCAACATGTCCTTCTTGCTT-ATGTTCCCAGCCTTG-3′).
To achieve approximately wild-type levels of tatBC expression, plasmid p101C*BC was constructed as follows: First the tatBC genes were amplified from pTAT101 (16) using primers tatBC2 (5′-GCAGATCGGATCCGTGTTTG-3′) and THfwd (5′-AGT-TAGCTCACTCATTAGGC-3′). The amplicon was digested with BamHI and PstI and then was cloned into the same sites in pTAT101 to give pTatBC101. This construction places tatBC immediately downstream of the tatA promoter in the vector. To construct plasmid p101C*TatBC, P tatA -tatBC was subcloned as an EcoRI-PstI fragment from pTatBC101 into pTH19Cr (17) to make p101CTatBC. To reduce the level of tatBC expression from this plasmid, the ribosome-binding site was altered by sitedirected mutagenesis with primers TatBRBS*F (5′-CATCATC-TACCACAGAGCAGGATCCGTGTTTG-3′) and TatBRBS*R (5′-CAAACACGGATCCTGCTCTGTGGTAGATGATG-3′) generating p101C*TatBC. p101C*BC FEA was created by two rounds of site-directed mutagenesis of p101C*TatBC using the primers TatCF94AF (5′-CTATCAGGTGTGGGCAGCTAT-CGCCCCAGCGCTG-3′) and TatCF94AR (5′-CAGCGCTG-GGGCGATAGCTGCCCACACCTGATAG-3′) and primers TatCE103AF (5′-CGCTGTATAAGCATGCACGTCGCCTG-GTGG-3′) and TatCE103AR (5′-CCACCAGGCGACGTGC-ATGCTTATACAGCG-3′).
To produce plasmid p101C*TatCy, the tatC-yfp A206K gene was amplified from p552ABCy using primers BamHITatCF (5′-ATAGGATCCATGTCTGTAGAAGATACTCAACC-3′) and SphIYFPR (5′-TTAGCATGCTTACTTGTACAGCTCGTCC-ATG-3′). The amplicon was cloned behind the tatA promoter by insertion between the BamHI and SphI sites of p101CTatBC to give the plasmid p101CTatCy. To reduce the expression level of tatC-yfp, the ribosome-binding site and start codon of p101CTatCy were altered by site-directed mutagenesis with primers TatCRBS*F (5′-CATCTACCACAGAGCAGGATCCGTGTCTGTAGAAG-ATAC-3′) and TatCRBS*R (5′-GTATCTTCTACAGACA-CGGATCCTGCTCTGTGGTAGATG-3′), yielding plasmid p101C*TatCy.
To construct plasmid p101KTatBy, the tatB-yfp A206K gene was amplified from genomic DNA isolated from strain DADE-λAByC using primers BamHITatBF (5′-CCGGATCCGTGTTTGATA-TCGGTTTTAGCGAACTGC-3′) and SphIYFPR and then was digested with BamHI and SphI. pTatBC101 was digested with the same enzymes to release the tatBC insert (but not the tatA promoter) from this plasmid, which then was replaced with the tatB-yfp PCR product.
To construct plasmid pGTGAryBC, an EcoRI-BamHI fragment encompassing P tatA -tatA-EAK-eyfp A206K was excised from pBSTatAry and was subcloned into the same sites in p101CTatBC, replacing the promoter upstream of tatB and tatC, to give plasmid p101AryBC. p101AryBC was subject to site-directed mutagenesis with primers TatAGTGF (5′-CATCTACCACAGAGGAACA-TGTGTGGGTGGTATCAGTATTTGGC-3′) and TatAGTGR (5′-GCCAAATACTGATACCACCCACACATGTTCCTCTG-TGGTAGATG-3′) to generate pGTGAryBC.
Analytical Methods. To assess the growth of strains with trimethylamine N-oxide (TMAO) as the terminal electron acceptor, a 25-mL universal tube was filled to the top with 29 mL LB medium + 0.5% (vol/vol) glycerol + 0.4% (wt/vol) TMAO (LB/ glycerol/TMAO medium) and was inoculated with 0.25 mL of an overnight aerobic culture. The tube was then incubated at 37°C without shaking.
Cells for TMAO reductase activity assays were cultured by inoculating 50 mL of LB/glycerol/TMAO medium with 250 μL of an aerobic preculture in a 50-mL Falcon tube and incubating overnight at 37°C without shaking. Periplasmic TMAO reductase activity in whole cells was measured spectrophotometrically as the substrate-dependent oxidation of reduced benzyl viologen (18, 19) . Because TMAO is essentially impermeable to the cytoplasmic membrane, this assay specifically measures enzyme that has been transported to the periplasm (20) .
Subcellular fractionation was carried out on cells cultured as for the microscopy experiments (described below). Membranes and periplasm were isolated using previously described methods (19, 21) . Immunoblotting analysis was carried out as described (22) , and immunoreactive bands were visualized with the ECL detection system (GE Healthcare).
Cell Preparation for Microscopy. A coverslip was fixed to a microscope slide using double-sided adhesive tape to form a tunnel slide, and the inside surface of the coverslip was coated with poly-L-lysine. An exponential-phase culture of cells grown aerobically in LB medium at 37°C (or 30°C for experiments involving CueO expression) was washed once in M9 minimal medium (23) containing 0.4% glucose, immobilized on the poly-L-lysine-coated coverslip, and then washed once with M9/glucose medium. For experiments involving overproduction of CueO or HiPIP from the appropriate expression plasmid, 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the early exponentialphase culture, which was then incubated at 30°C (for CueO) or 37°C (for HiPIP) for 30 min. Cells were then prepared for microscopy as described above except for the addition of 1 mM IPTG and 0.1 mg/mL ampicillin to all wash buffers.
For depolarization of cells by colicin E1, purified, lyophilized ColE1 (a gift from Colin Kleanthous, University of Oxford, Oxford, UK) was dissolved in 25 mM Tris·HCl (pH 7.4) at 1 mg/ mL. This solution was added directly to M9/glucose medium to a final concentration of 10 μg/mL. Immobilized cells were washed with the ColE1-containing medium and then were incubated for at least 3 min before image capture.
For nigericin/valinomycin treatment, cells were first permeabilized by treatment with M9/glucose medium containing 5 mM EDTA for 10 min at room temperature. Cells were then reisolated by centrifugation, suspended in fresh M9/glucose medium, and immobilized on tunnel slides as described above. Nigericin was dissolved in ethanol at 5 mM to give a 100× stock solution, and valinomycin was dissolved in DMSO at 8 mg/mL to give a 200× stock solution. The two ionophores then were diluted into M9/glucose medium containing 400 mM potassium acetate. A mock buffer of M9/glucose medium containing the same concentrations of potassium acetate, ethanol, and DMSO was also prepared. Immobilized EDTA-treated cells were washed with either the buffer containing valinomycin/nigericin or the mock buffer before image capture. This work *All strains designated "-A" are arabinose-resistant derivatives.
Movie S6. Strain ACE pBy. In the presence of TatC, TatB-YFP forms bright, mobile foci. Pixels below 1,000 a.u. are shown as black, and those above 7,000 a.u. are shown as white. Playback has been slowed 5× (20 frames at 20-ms exposure time). The area displayed is 8.8 μm 2 .
Movie S6
Movie S5. Time-lapse imaging of bME-induced recovery of TatAy spots in an AyBCE pCueO cell after CCCP dissipation (Fig. 6F) . βME (0.05%) was introduced at 10 s (between frames 1 and 2). Pixels below 1,000 a.u. are shown as black, and those above 7,000 a.u. are shown as white. Each frame in the video represents a single 20-ms exposure, with a 20-s delay between exposures. Playback is at five frame/s (100× speed). The area displayed is 8.8 μm 2 .
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